Prognostic impacts of hypoxic markers in soft tissue sarcoma

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Smeland, Eivind ^a,b   Kilvaer, Thomas K ^a   Sorbye, Sveinung ^a,b   Valkov, Andrej ^a,b   Andersen, Sigve ^a,b   Bremnes, Roy M ^a,b   Busund, Lill Tove ^a,b   Donnem, Tom ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA;

ADULT; ANGIOSARCOMA; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; FIBROSARCOMA; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; NEUROFIBROSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TISSUE MICROARRAY;

EID: 84858122192     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/541650     Document Type: Article

References (59)

1. Pouysségur J., Dayan F., Mazure N. M., Hypoxia signalling in cancer and approaches to enforce tumour regression Nature 2006 441 7092 437 443 (Pubitemid 44050138)
2. Airley R. E., Phillips R. M., Evans A. E., Double J., Burger A. M., Feibig H. H., West C. M., Stratford I. J., Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts International Journal of Oncology 2005 26 6 1477 1484
3. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P., Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Research 1996 56 19 4509 4515 (Pubitemid 26330463)
4. Brizel D. M., Scully S. P., Harrelson J. M., Layfield L. J., Bean J. M., Prosnitz L. R., Dewhirst M. W., Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Research 1996 56 5 941 943 (Pubitemid 26065381)
5. Nordsmark M., Hoyer M., Keller J., Nielsen O. S., Jensen O. M., Overgaard J., The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas International Journal of Radiation Oncology Biology Physics 1996 35 4 701 708 (Pubitemid 26251125)
6. Mortensen L. S., Buus S., Nordsmark M., Bentzen L., Munk O. L., Keiding S., Overgaard J., Identifying hypoxia in human tumors: a correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode Acta Oncologica 2010 49 7 934 940
7. Kaluz S., Kaluzov M., Liao S. Y., Lerman M., Stanbridge E. J., Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show? Biochimica et Biophysica Acta, Reviews on Cancer 2009 1795 2 162 172
8. Vordermark D., Brown J. M., Endogenous markers of tumor hypoxia: predictors of clinical radiation resistance? Strahlentherapie und Onkologie 2003 179 12 801 811 (Pubitemid 37509467)
9. Jankovic B., Aquino-Parsons C., Raleigh J. A., Stanbridge E. J., Durand R. E., Banath J. P., MacPhail S. H., Olive P. L., Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix Cytometry Part B, Clinical Cytometry 2006 70 2 45 55
10. Mayer A., Hockel M., Vaupel P., Endogenous hypoxia markers: case not proven! Advances in Experimental Medicine and Biology 2008 614 127 136
11. Semenza G. L., Wang G. L., A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Molecular and Cellular Biology 1992 12 12 5447 5454
12. Tian H., McKnight S. L., Russell D. W., Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells Genes and Development 1997 11 1 72 82 (Pubitemid 27043825)
13. Heidbreder M., Frohlich F., Johren O., Dendorfer A., Qadri F., Dominiak P., Hypoxia rapidly activates HIF-3alpha mRNA expression The FASEB Journal 2003 17 11 1541 1543
14. Gu Y. Z., Moran S. M., Hogenesch J. B., Wartman L., Bradfield C. A., Molecular characterization and chromosomal localization of a third -class hypoxia inducible factor subunit, HIF3 Gene Expression 1998 7 3 205 213 (Pubitemid 28527216)
15. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y., A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1 regulates the VEGF expression and is potentially involved in lung and vascular development Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4273 4278
16. Zhong H., de Marzo A. M., Laughner E., Lim M., Hilton D. A., Zagzag D., Buechler P., Isaacs W. B., Semenza G. L., Simons J. W., Overexpression of hypoxia-inducible factor 1{{ }} in common human cancers and their metastases Cancer Research 1999 59 22 5830 5835
17. Semenza G. L., Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 2010 29 5 625 634
18. Warburg O., On the origin of cancer cells Science 1956 123 3191 309 314
19. Kunkel M., Reichert T. E., Benz P., Lehr H. A., Jeong J. H., Wieand S., Bartenstein P., Wagner W., Whiteside T. L., Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma Cancer 2003 97 4 1015 1024 (Pubitemid 36173153)
20. Younes M., Lechago L. V., Somoano J. R., Mosharaf M., Lechago J., Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers Cancer Research 1996 56 5 1164 1167 (Pubitemid 26065417)
21. Cantuaria G., Fagotti A., Ferrandina G., Magalhaes A., Nadji M., Angioli R., Penalver M., Mancuso S., Scambia G., GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy Cancer 2001 92 5 1144 1150 (Pubitemid 32861663)
22. Haber R. S., Rathan A., Weiser K. R., Pritsker A., Itzkowitz S. H., Bodian C., Slater G., Weiss A., Burstein D. E., GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis Cancer 1998 83 1 34 40 (Pubitemid 28299626)
23. Younes M., Brown R. W., Stephenson M., Gondo M., Cagle P. T., Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival Cancer 1997 80 6 1046 1051 (Pubitemid 27427603)
24. Brahimi-Horn M. C., Chiche J., Pouysségur J., Hypoxia and cancer Journal of Molecular Medicine 2007 85 12 1301 1307 (Pubitemid 50004093)
25. Chiche J., Ilc K., Laferrire J., Trottier E., Dayan F., Mazure N. M., Brahimi-Horn M. C., Pouysségur J., Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH Cancer Research 2009 69 1 358 368
26. Semenza G. L., Regulation of cancer cell metabolism by hypoxia-inducible factor 1 Seminars in Cancer Biology 2009 19 1 12 16
27. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009 CA Cancer Journal for Clinicians 2009 59 4 225 249
28. Blay J. Y., von Mehren M., Blackstein M. E., Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors Cancer 2010 116 22 5126 5137
29. Kilvaer T. K., Valkov A., Sorbye S., Smeland E., Bremnes R. M., Busund L. T., Donnem T., Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis PLoS One 2010 5 12
30. Fletcher C. D. M., The evolving classification of soft tissue tumours: an update based on the new WHO classification Histopathology 2006 48 1 3 12
31. Guillou L., Coindre J. M., Bonichon F., Bui N. B., Terrier P., Collin F., Vilain M. O., Mandard A. M., Le Doussal V., Leroux A., Jacquemier J., Duplay H., Sastre-Garau X., Costa J., Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma Journal of Clinical Oncology 1997 15 1 350 362 (Pubitemid 27020593)
32. Donnem T., Al-Saad S., Al-Shibli K., Delghandi M. P., Persson M., Nilsen M. N., Busund L. T., Bremnes R. M., Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non-small cell lung cancer Clinical Cancer Research 2007 13 22 6649 6657 (Pubitemid 350206800)
33. Koukourakis M. I., Bentzen S. M., Giatromanolaki A., Wilson G. D., Daley F. M., Saunders M. I., Dische S., Sivridis E., Harris A. L., Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial Journal of Clinical Oncology 2006 24 5 727 735 (Pubitemid 46622039)
34. Choi Y. S., Kim S. J., Kim D. S., Glucose transporter-1 expression in squamous cell carcinoma of the tongue Cancer Research and Treatment 2007 29 109 115
35. Ozbudak I. H., Shilo K., Tavora F., Rassaei N., Chu W. S., Fukuoka J., Jen J., Travis W. D., Franks T. J., Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis Modern Pathology 2009 22 5 633 638
36. Woelber L., Kress K., Kersten J. F., Choschzick M., Kilic E., Herwig U., Lindner C., Schwarz J., Jaenicke F., Mahner S., Milde-Langosch K., Mueller V., Ihnen M., Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer BMC Cancer 2011 11, article 12
37. Ahrens W. A., Ridenour R. V. III, Caron B. L., Miller D. V., Folpe A. L., GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms Human Pathology 2008 39 10 1519 1526
38. Endo M., Tateishi U., Seki K., Yamaguchi U., Nakatani F., Kawai A., Chuman H., Beppu Y., Prognostic implications of glucose transporter protein-1 (Glut-1) overexpression in bone and soft-tissue sarcomas Japanese Journal of Clinical Oncology 2007 37 12 955 960 (Pubitemid 351176488)
39. Tateishi U., Yamaguchi U., Seki K., Terauchi T., Arai Y., Hasegawa T., Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography European Journal of Nuclear Medicine and Molecular Imaging 2006 33 6 683 691 (Pubitemid 43846759)
40. Nagamatsu A., Umesaki N., Li L., Tanaka T., Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas Oncology Reports 2010 23 4 1069 1076
41. Wang Y., Li Z., Zhang H., Jin H., Sun L., Dong H., Xu M., Zhao P., Zhang B., Wang J., Pan Y., Liu L., HIF-1 and HIF-2 correlate with migration and invasion in gastric cancer Cancer Biology and Therapy 2010 10 4 376 382
42. Shintani K., Matsumine A., Kusuzaki K., Matsubara T., Satonaka H., Wakabayashi T., Hoki Y., Uchida A., Expression of hypoxia-inducible factor (HIF)-1 as a biomarker of outcome in soft-tissue sarcomas Virchows Archiv 2006 449 6 673 681 (Pubitemid 44832639)
43. Yoshimura H., Dhar D. K., Kohno H., Kubota H., Fujii T., Ueda S., Kinugasa S., Tachibana M., Nagasue N., Prognostic impact of hypoxia-inducible factors 1 and 2 in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression Clinical Cancer Research 2004 10 24 8554 8560 (Pubitemid 40053424)
44. Giatromanolaki A., Koukourakis M. I., Sivridis E., Turley H., Talks K., Pezzella F., Gatter K. C., Harris A. L., Relation of hypoxia inducible factor 1 and 2 in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival British Journal of Cancer 2001 85 6 881 890 (Pubitemid 33010557)
45. Li Q. F., Wang X. R., Yang Y. W., Lin H., Hypoxia upregulates hypoxia inducible factor (HIF)-3 expression in lung epithelial cells: characterization and comparison with HIF-1 Cell Research 2006 16 6 548 558
46. Uchida T., Rossignol F., Matthay M. A., Mounier R., Couette S., Clottes E., Clerici C., Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1 and HIF-2 expression in lung epithelial cells: implication of natural antisense HIF-1 Journal of Biological Chemistry 2004 279 15 14871 14878
47. Ishibashi H., Nakagawa K., Onimaru M., Castellanous E. J., Kaneda Y., Nakashima Y., Shirasuna K., Sueishi K., Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor/ 1, and tissue factor and also cell growth and invasion activities Cancer Research 2000 60 22 6531 6536
48. Pore N., Gupta A. K., Cerniglia G. J., Jiang Z., Bernhard E. J., Evans S. M., Koch C. J., Hahn S. M., Maity A., Nelfinavir down-regulates hypoxia-inducible factor 1 and VEGF expression and increases tumor oxygenation: implications for radiotherapy Cancer Research 2006 66 18 9252 9259 (Pubitemid 44521147)
49. Boeuf S., Bovée J. V. M. G., Lehner B., Hogendoorn P. C. W., Richter W., Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours Histopathology 2010 56 5 641 651
50. Woelber L., Mueller V., Eulenburg C., Schwarz J., Carney W., Jaenicke F., Milde-Langosch K., Mahner S., Serum carbonic anhydrase IX during first-line therapy of ovarian cancer Gynecologic Oncology 2010 117 2 183 188
51. Leibovich B. C., Sheinin Y., Lohse C. M., Thompson R. H., Cheville J. C., Zavada J., Kwon E. D., Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma Journal of Clinical Oncology 2007 25 30 4757 4764 (Pubitemid 350086478)
52. Lie M., Mazure N. M., Hofman V., Ammadi R. E., Ortholan C., Bonnetaud C., Havet K., Venissac N., Mograbi B., Mouroux J., Pouysségur J., Hofman P., High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer British Journal of Cancer 2010 102 11 1627 1635
53. Eckert A. W., Lautner M. H. W., Schtze A., Bolte K., Bache M., Kappler M., Schubert J., Taubert H., Bilkenroth U., Co-expression of Hif1 and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients Journal of Oral Pathology and Medicine 2010 39 4 313 317
54. Lapi S. E., Voller T. F., Welch M. J., Positron emission tomography imaging of hypoxia PET Clinics 2009 4 39 47
55. Sauter, Tissue Microarrays 2010 Springer
56. Kallioniemi O. P., Wagner U., Kononen J., Sauter G., Tissue microarray technology for high-throughput molecular profiling of cancer Human Molecular Genetics 2001 10 7 657 662 (Pubitemid 32331572)
57. Dikmen Z. G., Gellert G. C., Dogan P., Yoon H., Young B. L., Chang H. A., Shay J. W., In vivo and in vitro effects of a HIF-1 inhibitor, RX-0047 Journal of Cellular Biochemistry 2008 104 3 985 994 (Pubitemid 351830845)
58. Semenza G. L., Evaluation of HIF-1 inhibitors as anticancer agents Drug Discovery Today 2007 12 19-20 853 859 (Pubitemid 47554628)
59. Thiry A., Dogne J. M., Masereel B., Supuran C. T., Targeting tumor-associated carbonic anhydrase IX in cancer therapy Trends in Pharmacological Sciences 2006 27 11 566 573 (Pubitemid 44574507)